We are live on
!
Find out more
DCM
DAFNA Capital Management Portfolio holdings
AUM
$524M
1-Year Est. Return
164.42%
This Fund
S&P 500
This Quarter
Est. Return
+7.4%
1 Year Est. Return
+164.42%
3 Year Est. Return
+313.04%
5 Year Est. Return
+302.83%
10 Year Est. Return
+4,361.99%
AUM
$68.3M
AUM Growth
–
Cap. Flow
+$61.3M
Cap. Flow
% of AUM
89.65%
Top 10 Holdings %
Top 10 Hldgs %
62.8%
Holding
44
New
40
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$8.35M |
| 2 |
NVDQ
Novadaq Technologies Inc.
NVDQ
|
+$5.92M |
| 3 |
Protalix BioTherapeutics
PLX
|
+$4.61M |
| 4 |
AtriCure
ATRC
|
+$4.16M |
| 5 |
Insulet
PODD
|
+$3.54M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 66.69% |
| 2 | Miscellaneous | 31.41% |
| 3 | Financials | 1.22% |
| 4 | Communication Services | 0.49% |
| 5 | Industrials | 0.19% |
Similar funds
4WM
BB
A
HW
DAM
SDWIA
SCA
BHPW
DAFNA Capital Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for DAFNA Capital Management, which disclosed 44 positions worth $68.3M. Its ten largest holdings account for 63% of the portfolio.
Its largest position is PHARMACYCLICS INC: 102,128 shares worth $8.12M.
By sector, the portfolio is most concentrated in Healthcare at 67% of assets, followed by Miscellaneous and Financials.
- DAFNA Capital Management's largest Q2 2013 buy was PHARMACYCLICS INC: 102,128 shares worth $8.12M.
- DAFNA Capital Management's ten largest holdings make up 63% of its $68.3M portfolio in Q2 2013.
- DAFNA Capital Management disclosed 44 positions in Q2 2013, its first 13F filing on record.
Based on DAFNA Capital Management's 13F filing for Q2 2013, filed 14 Aug 2013.